Background
==========

Diarrhea is a common symptom that accompanies many diseases and occurs as 2 types: acute diarrhea and chronic diarrhea \[[@b1-medscimonit-26-e920879]\]. Antibiotic-associated diarrhea (AAD) has become a serious public health problem. AAD is an enteric dysbacteriosis disease caused by the overuse of antibiotics, which kills antibiotic-sensitive strains while allowing resistant strains to not only survive but also thrive \[[@b2-medscimonit-26-e920879],[@b3-medscimonit-26-e920879]\]. As reported previously, the possible pathogenic features of AAD include interference with bacterial metabolism, disruption in the balance of intestinal bacteria, and reduction in disaccharidase (especially lactase) activity \[[@b4-medscimonit-26-e920879]\]. Our previous study determined that the lactase gene density of intestinal bacteria was reduced in AAD mice, and the ACE and Chao1 indices decreased. The abundance of some bacterial genera producing lactase was also decreased \[[@b5-medscimonit-26-e920879]\].

Intestinal lactase is mainly produced by microbes, such as *Lactobacillus* sp., *Escherichia coli*, *Bacillus* sp., *Bifidobacterium* sp., *Enterobacter aerogenes,* and *Streptococcus thermophilus*, although it is also produced by the intestinal mucosa, where it plays a critical role in modulating intestinal function \[[@b6-medscimonit-26-e920879]--[@b8-medscimonit-26-e920879]\]. Low activity and deficiency of lactase can induce diarrhea; in such cases, the symptoms can be improved if lactase is supplied \[[@b9-medscimonit-26-e920879],[@b10-medscimonit-26-e920879]\]. Interestingly, lactase can be destroyed by antibiotics, especially β-lactam antibiotics such as cefradine \[[@b11-medscimonit-26-e920879],[@b12-medscimonit-26-e920879]\]. Certain yeasts are probiotics that can confer a benefit to the host. These yeasts have the potential to treat diarrhea and dramatically alleviate symptoms \[[@b13-medscimonit-26-e920879]\]. The yeast *D. hansenii* can be isolated from food and the gut of experimental mice; it has important biotechnological potential in food and other industries \[[@b14-medscimonit-26-e920879],[@b15-medscimonit-26-e920879]\]. *D. hansenii* has been shown to adjust the microecosystem balance in AAD mice \[[@b14-medscimonit-26-e920879],[@b16-medscimonit-26-e920879]\]. Previous research on the impact of *D. hansenii* on AAD mainly focused on intestinal-cultured microbiota and various enzyme activities. A recent study reported that antibiotic-induced diarrhea was relieved by treatment with *D. hansenii* through adjustment of the richness and types of intestinal bacteria \[[@b17-medscimonit-26-e920879]\], although how *D. hansenii* affects bacterial functional genes is still unknown.

Because of its important role in human health, the gut microbiota has been a focus of research in recent years. Although 16S rRNA sequencing has been widely used for bacterial analysis, there have been few reports on the gut bacterial lactase gene or the sequencing of any other functional enzyme gene for bacterial analysis. As such, for the present study, a pair of special bacterial primers was designed and validated for amplifying the gut lactase gene \[[@b18-medscimonit-26-e920879]\]. The lactase gene sequencing results were used to probe the bacterial characteristics in the gut mucosa of AAD mice, and it was also used to explore the mechanism of Qiweibaizhu powder on AAD \[[@b19-medscimonit-26-e920879]\]. We previously found that the influence of Qiweibaizhu powder on bacteria in the intestinal mucosa of AAD mice was different from that on the intestinal contents of AAD mice \[[@b20-medscimonit-26-e920879]\]. Therefore, we aimed to investigate the therapeutic effect of *D. hansenii* on lactase from intestinal contents at the genetic level. The results suggest an experimental basis to explain the mechanism of *D. hansenii* on AAD. *D. hansenii* may be a novel microbioecologics.

Material and Methods
====================

Reagents and medicine
---------------------

*D. hansenii* was isolated from the mouse intestine and identified as described in a previous report \[[@b15-medscimonit-26-e920879]\]. We inoculated *D. hansenii* into potato sucrose liquid medium. Then, the*D. hansenii* was incubated for 36 h with shaking at 28°. After centrifugation at 2000 rpm for 4 min,*D. hansenii* cells were collected. The cells were repeatedly washed 2 times with sterile 0.85% NaCl solution to dislodge the medium component. Following this, the cells were counted by a hemocytometer and then diluted to 10^10^·mL^−1^ with an appropriate amount of sterile water. *D. hansenii* was stored at 4°C for use the next day \[[@b16-medscimonit-26-e920879]\].

Acetone, TE buffer, protease K, lysozyme, and phenol-chloroform-isoamyl alcohol (25: 24: 1/volume: volume: volume) were purchased from Dingguo Changsheng Biotechnology Company (Beijing, China). All other reagents for DNA extraction were prepared in our laboratory. Antibiotics were produced by Yichang Humanwell Pharmaceutical Company (Hubei, China) or Chung-Hwa Chemical & Pharmaceutical Industrial Company (Suzhou, Jiangsu, China).

PCR primers were 5′-TRRGCAACGAATACGGSTG-3′ (F) and 5′-ACCATGAARTTSGTGGTSARCGG-3′ (R), which were synthesized from Personal Biotechnology Company of Shanghai, China \[[@b18-medscimonit-26-e920879],[@b19-medscimonit-26-e920879]\].

Animals and procedures
----------------------

All mice (1 month old, weight 18--22 g) were specific pathogen-free (SPF). We purchased these mice from Hunan Slaccas Jingda Laboratory Animal Company. The sex ratio was male: female=1: 1 \[SCXK (Xiang) 2013-0004\]. All experiments involving animals were carried out following the relevant protocols and were approved by the university Animal Care and Use Committee. All tested mice were randomly divided into 3 groups: a model group (tlmn), a normal group (tlcn), and a *D. hansenii* group (tljn). There were 6 mice in each group (3 males and 3 females). The mice were kept in separate cages in a clean and quiet environment at 23--25°C and 50--70% humidity. To create the diarrhea model, the tlmn and tljn groups were intragastrically administered 0.35 mL 62.5 g/L (40 000 U/mL) cefradine capsule and gentamycin sulfate mixture, while the mice in the tlcn group were intragastrically administered 0.35 mL distilled water. All mice were intragastrically treated twice a day for 5 continuous days. After the AAD was established successfully, the model mice had symptoms of watery stool, erect coat, reduced food intake, and decreased activity. *D. hansenii* solution (0.35 mL, 10^10^·mL^−1^) \[[@b21-medscimonit-26-e920879]\] was administered to the tljn group mice twice a day for a total of 3 days. The tlcn and tlmn groups mice were intragastrically injected with 0.35 mL distilled water. Mice were then euthanized by cervical dislocation; then, the intestinal contents of the mice were collected for subsequent experiments \[[@b22-medscimonit-26-e920879]\]. Each sample contained mixed fecal material derived from 2 mice (1 male and 1 female).

Total DNA extraction from intestinal contents
---------------------------------------------

The total DNA of the intestinal content was extracted following previously reported protocols \[[@b17-medscimonit-26-e920879],[@b23-medscimonit-26-e920879]\]. The intestinal contents were washed twice with phosphate buffer solution (PBS) (0.1 mol·L^−1^). Subsequently, we transferred all the supernatants to fresh tubes, and the supernatants were centrifuged to collect the new sediment. The sediments were resuspended in TE buffer. The sediments were cleaned 1 time with PBS, 2 times with acetone, and 3 times with PBS. The sediments were incubated with proteinase K and lysozyme to release nucleic acids and other substances. Then, the DNA was dissolved into 50 μL TE buffer component for further analysis after being purified and extracted by CTAB/NaCl, phenol-chlororom-isoamyl alcohol (25: 24: 1/volume: volume: volume) saturated with Tris, chloroform-isoamyl alcohol (24: 1/volume: volume), absolute ethyl alcohol, and sodium acetate.

PCR amplification and sequencing
--------------------------------

As in our previous report \[[@b18-medscimonit-26-e920879]\], bacterial lactase genes were PCR-amplified with our universal primers. The PCR mixture (25 μL volume) was composed of 5 μL 5×reaction buffer, 5 μL 5×high GC buffer, 0.5 μL 10 mmol/L dNTPs, 0.25 μL Q5 high-fidelity DNA polymerase, 1 μL 10 μmol/L each forward primer and reverse primer, 1 μL extracted DNA, and 11.25 μL sterilized ddH~2~O. The PCR was performed with initial denaturation at 98°C for 30 s, followed by denaturation at 98°C for 15 s, annealing at 46°C for 30 s, and extension at 72°C for 30 s, for a total of 32 cycles, a final extension cycle at 72°C for 5 min, and holding at 4°C. All the PCR products were determined by 2% agarose electrophoresis. Then, PCR products were sequenced by using the Illumina MiSeq method for bacterial lactase gene diversity. The sequencing service was provided by Personal Biotechnology Company (Shanghai).

Data analyses
-------------

Sequences were analyzed online using QIIME software \[[@b24-medscimonit-26-e920879]\] (*<http://qiime.org/>*) and Mothur software (*<http://www.mothur.org/>*). To analyze lactase gene diversity, 3 methods were used to determine the operational taxonomic units (OTUs): alpha diversity analysis (ADA), community composition analysis (CCA), and principal components analysis (PCA) \[[@b25-medscimonit-26-e920879]--[@b27-medscimonit-26-e920879]\]. Significant differences between different groups were determined using one-way ANOVA in SPSS 20.0. *P*\<0.05 was regarded as a significant difference.

Results
=======

Sample sequences and operational taxonomic units
------------------------------------------------

The lactase gene sequencing data were analyzed by QIIME software (version 1.7.0, *<http://qiime.org/>*) to compare their homogeneity following initial filtering by Uchime software (version 1.35.1, *<http://www.mothur.org/>*) to remove the chimeric sequences. According to the sequencing results, there were 670 308 effective sequences and 658 355 high-quality sequences. In brief, the proportion of the bacterial lactase gene out of the total lactase gene was approximately 98% for each group.

According to gene homogeneity, the lactase gene sequences with over 97% similarity would be aligned and grouped into a single OTU. There were 1056, 1143, and 443 OTUs in the normal group, model group, and *D. hansenii* group, respectively. A total of 1348 OTUs were identified; with 122, 186, and 52 OTUs uniquely identified in these 3 groups, respectively ([Figure 1](#f1-medscimonit-26-e920879){ref-type="fig"}). The results suggested that the variety of bacterial lactase genes decreased after treatment with *D. hansenii*.

Alpha diversity of lactase genes in AAD mice treated with *D. hansenii*
-----------------------------------------------------------------------

Rarefaction analysis showed that the OTUs of 9 samples gradually increased with the increasing number of measured sequences. Furthermore, the curve flattened, and the increasing trend decreased. These results indicated that the sequencing depth was sufficient to analyze the bacterial lactase gene characteristics. The diversity of the bacterial lactase gene in the *D. hansenii* treatment group was the lowest ([Figure 2](#f2-medscimonit-26-e920879){ref-type="fig"}).

The ACE, Chao1, and Shannon indices of lactase genes in the normal group and the model group were not significantly different, but the Chao1 and Shannon indices decreased significantly in the *D. hansenii* group compared with the other 2 groups (*P*\<0.01). These results indicated that the community diversity of lactase-producing bacteria from intestinal contents of AAD mice had not recovered after being treated with *D. hansenii* ([Table 1](#t1-medscimonit-26-e920879){ref-type="table"}).

Intestinal lactase gene beta diversity in AAD mice treated with *D. hansenii*
-----------------------------------------------------------------------------

PCA analysis was conducted to measure differences in communities of lactase-producing bacteria at the genus level. The results show that the gene clusters of the *D. hansenii* group were quite different from those of the normal group and model group. This suggests that the bacterial community structure in the *D. hansenii* group was different from those in the normal group and model group. It also showed that there was little difference between the normal group and model group. The variation percentages of PC1 and PC2 were 99.22% and 0.73%, respectively ([Figure 3](#f3-medscimonit-26-e920879){ref-type="fig"}).

Intestinal lactase gene origination and abundance in AAD mice treated with *D. hansenii*
----------------------------------------------------------------------------------------

The results showed that intestinal lactase mainly originated from Actinobacteria, Firmicutes, and Proteobacteria ([Figure 4](#f4-medscimonit-26-e920879){ref-type="fig"}), and Proteobacteria was the richest. Compared to the normal group and model group, we found that *D. hansenii* increased the richness of lactase genes originating from *Enterobacter* sp. 638.

At the genus level, there were 24, 27, and 8 known sources in the normal group, model group, and *D. hansenii* group, respectively. Lactase-producing bacteria such as*Paenibacillus*, *Rhodococcus,* and *Ensifer* were exclusively detected in the normal group mice, while *Micromonospora*, *Rhizobium*, *Methylarcula*, *Ruminococcus*, *Novosphingobium,* and *Stenotrophomonas* were present only in the model group mice ([Figure 5](#f5-medscimonit-26-e920879){ref-type="fig"}). In addition, most lactase-producing strains were unclassified bacteria or novel strains. After modeling, the quantity of the lactase gene originating from *Fretibacterium* was significantly increased, and it was recovered by *D. hansenii*. Similarly, after treatment with *D. hansenii*, the richness of detected genera in the *D. hansenii* group was lower than that in the other 2 groups, and, with the exception of *Modestobacter*, the richness was increased in the *D. hansenii* group.

Discussion
==========

Approximately 1000 species of bacteria and approximately 10^14^ microbes inhabit the human intestinal tract \[[@b28-medscimonit-26-e920879]\]. It is well known that intestinal microbiota plays critical roles in metabolism, nutrient digestibility, and immunity \[[@b29-medscimonit-26-e920879]\]. Furthermore, intestinal microorganisms are a source of lactase \[[@b30-medscimonit-26-e920879]\]. Antibiotics save lives by combatting bacterial infections. Unfortunately, misuse of antibiotics frequently results in antibiotic-associated diarrhea in patients. The symptoms can be reduced or prevented using probiotics, such as *D. hansenii* \[[@b17-medscimonit-26-e920879]\].

Sequence quality was critical to the following sequencing and analysis. Our results showed that the high-quality sequences from each group were more than 97%, which ensured the accuracy and reliability of the subsequent analysis. In this study, all the bacterial lactase gene OTU numbers and Chao1 index and Shannon index values in intestinal contents were lowest in the *D. hansenii* group (*P*\<0.01). These results showed that *D. hansenii* remarkably decreased the density and homogeneity of the lactase gene in comparison with the other 2 groups. PCA showed that genes in the *D. hansenii* group were clearly distinguishable from those in the normal group and model group, indicating that *D. hansenii* changed the community structure of lactase-producing bacteria.

The gut bacteria of the mice comprised Bacteroidetes, Firmicutes, Actinobacteria, Proteobacteria, and Verrucomicrobia at the phylum level \[[@b17-medscimonit-26-e920879]\]. Lactase-producing genes in the intestine are mainly derived from Actinobacteria, Firmicutes, Proteobacteria, and other, unclassified, species. At the genus level, the number of lactase-producing species was lowest in the *D. hansenii* treatment group. Moreover, bacterial lactase genes from *Rhodococcus*, *Paenibacillus*, and *Ensifer* existed exclusively in the normal group, while those from *Micromonospora*, *Ruminococcus*, *Rhizobium*, *Methylarcula*, *Novosphingobium,* and *Stenotrophomonas* were detected only in the model group, which confirmed that the microbial communities had been changed by *D. hansenii*. Following treatment with *D. hansenii*, the abundance of lactase genes from *Fretibacterium* recovered significantly (*P*\<0.01). It was also reported that cells of the strain of *Fretibacterium* were asaccharolytic \[[@b31-medscimonit-26-e920879]\]. *Enterobacter* sp. 638 was previously studied, and the genetic determinants required for sucrose metabolism are clustered on a genomic island \[[@b32-medscimonit-26-e920879]\]. In the present study, the results showed that treatment with *D. hansenii* increased the lactase gene from *Enterobacter* sp. 638. The abundance analysis also demonstrated that all bacterial lactase genes detected from intestinal contents, other than *Modestobacter*, were the lowest in the *D. hansenii* group. In conclusion, we speculate that *Fretibacterium*, *Modestobacter,* and *Enterobacter* sp. 638 are closely related to lactose metabolism. In addition, *D. hansenii* increased the number of unclassified lactase-producing bacteria.

Conclusions
===========

In summary, the bacterial lactase gene diversity was decreased by *D. hansenii*. The improvement in lactase activity appears to be associated with the increasing abundance of several pivotal lactase-producing strains and the intestinal microflora balance reestablished by *D. hansenii*, thus treating AAD.
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![Bacterial lactase gene OTUs of intestinal contents. tlcn represents the normal group, tlmn represents the model group, and tljn represents the *D. hansenii* group.](medscimonit-26-e920879-g001){#f1-medscimonit-26-e920879}

![Rarefaction curve of gene from each sample. The abscissa represents the number of lactase gene sequences extracted randomly; the ordinate represents the number of observed OTUs of the lactase gene. The data indicate that the sequencing tended to be saturated and that increasing the amount of data would have no significant effect on obtaining a new OTU when the curve tended to be flat. tlcn1--3, tlmn1--3, and tljn1-3 represent normal groups 1--3, model groups 1--3, and *D. hansenii* groups 1--3, respectively.](medscimonit-26-e920879-g002){#f2-medscimonit-26-e920879}

![Community difference of bacterial lactase gene from intestinal contents. Different color points represent samples from different groups. A shorter distance between 2 points represents a smaller community difference of bacteria between the 2 groups. tlcn -- normal group; tlmn -- model group; tljn -- *D. hansenii* group.](medscimonit-26-e920879-g003){#f3-medscimonit-26-e920879}

![Lactase gene from intestinal contents of mice. The pie chart for each branch node indicated the abundance of this taxon in the sample; the larger the fan area, the higher the richness of lactase gene was. tlcn -- normal group; tlmn -- model group; tljn -- *D. hansenii* group.](medscimonit-26-e920879-g004){#f4-medscimonit-26-e920879}

![Relative abundance of the bacterial lactase gene at the genus level. tlcn -- normal group mice; tlmn -- model group mice; tljn -- *D. hansenii* group mice.](medscimonit-26-e920879-g005){#f5-medscimonit-26-e920879}

###### 

Alpha index of lactase genes in AAD mice treated with *D. hansenii.*

  Groups   Chao1 index                                                                                                                 ACE index       Shannon index
  -------- --------------------------------------------------------------------------------------------------------------------------- --------------- -------------------------------------------------------------------------------------------------------------------------
  tlcn     532.00±48.14                                                                                                                570.22±77.44    5.30±0.24
  tlmn     517.00±116.35                                                                                                               585.54±148.49   5.12±0.33
  tljn     148.33±5.77[\*](#tfn2-medscimonit-26-e920879){ref-type="table-fn"}[\#](#tfn3-medscimonit-26-e920879){ref-type="table-fn"}   184.19±24.44    3.42±0.51[\*](#tfn2-medscimonit-26-e920879){ref-type="table-fn"}[\#](#tfn3-medscimonit-26-e920879){ref-type="table-fn"}

tlcn -- normal group mice; tlmn -- model group mice; tljn -- *D. hansenii* group mice.

*P*\<0.01 *vs.* the normal group;

*P*\<0.01 *vs.* the model group.
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